Navigation Links
Ann Arbor firm with UW drug tech goes public

QuatRx Pharmaceuticals Co., a pharmaceutical firm in Ann Arbor, Michigan, that licensed some of University of Wisconsin-Madison professor Hector DeLuca's technology in 2002, has filed for an IPO.

One of the company's five products is a treatment for psoriasis, a skin disease, based on DeLuca's work at UW-Madison and Deltanoid Pharmaceuticals. It is licensed through the Wisconsin Alumni As......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 02/15/06


Page: 1

Related biology technology :

1. 2006: A great biotech financing year, unless you were going public!
2. TomoTherapys 100th radiology system reaches public sector
3. With patents and research tools, when is private really public?
4. Brady Corp. raises $137 million in public offering
5. In public attitudes about taxes and spending, Wisconsin is Jekyll and Hyde
6. Republican sees nothing wrong with Doyles use of executive order
7. Anthropology professors blog raises public interest
8. Building the modern public-purpose university should be UW Systems goal
9. Republicans propose sweeping changes to promote investment
10. UW offers new program in neuroscience and public policy
11. Funds will support public safety communications interoperabilty
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... ... of the Modular Building Institute (MBI), an international modular trade organization, were awarded ... modular category for the Pagliuca Life Lab at Harvard University. The awards were ...
(Date:3/28/2017)... March 28, 2017 Volition America, Inc., a wholly-owned ... the engagement of Deborah Vollmer Dahlke , DrPH, CEO ... Dr. Vollmer Dahlke,s role will be to assist ... State of Texas and elsewhere in ... Dahlke has significant experience over the past six years, ...
(Date:3/28/2017)... , March 28, 2017 Dr. ... international life sciences corporation Anpac Bio-Medical Science ... a new, international record, processing and reporting over ... "Cancer Differentiation Analysis" (CDA) liquid biopsy tests. ... Nobel Prize Laureate Summit publications, Anpac Bio,s CDA ...
(Date:3/28/2017)... ... 2017 , ... Currently symptomatic therapies for Parkinson’s Disease (PD) ... in STEM CELLS suggests that human neural stem cell (hNSC) transplantation could help ... neural cells. , Strategies involving transplantation of these cells into the affected ...
Breaking Biology Technology:
(Date:2/28/2017)... News solutions for biometrics, bag drop and ... ... to 16 March, Materna will present its complete end-to-end passenger ... is a real benefit for passengers. To accelerate the whole ... touch point solutions to take passengers through the complete integrated ...
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
Breaking Biology News(10 mins):